Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Maryland, Baltimore
With
Maryland Industrial Partnerships
Telcare, Inc
This research program will enroll participants in a 6-month pilot intervention study. In this study, 100 patients with diabetes (Type 1 and Type 2) who are known to be non-compliant with SMBG will be enrolled and randomized to treatment groups (one group will receive a standard glucose meter and the second group will receive the cellular-embedded device) in order to achieve the following specific study aims;
Primary Aim 1: Determine if connecting diabetic patients to care managers via a cellular-enabled glucose meter with feedback will improve SMBG testing compliance.
Secondary Aim 2: Determine if increased testing compliance leads to improvement in overall blood glucose control. This will be measured by a reduction of HbA1c levels.
Secondary Aim 3: Determine whether this intervention leads to significant improvements in patient satisfaction with self-care and patient self-assessment of compliance.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age and older
Diagnosis of Diabetes Mellitus (Type 1 or Type 2)
Currently, non-compliant with prescribed glucose testing regimen
HbA1c of 7.5 or greater within the last six months
You may not be if
Actively being treated for substance abuse
Treatment for a thought disorder within the past year
Non-English speaking
Persons who are legally blind
Women who are pregnant
Cognitively or decisionally impaired as determined by practitioner
